NCT00563056View on ClinicalTrials.gov

An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma

PHASE3CompletedINTERVENTIONAL

Enrollment

227

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Asthma Bronchiale

Interventions

DRUG

Flutiform

DRUG

Flixotide plus Foradil

Trial Locations (6)

Unknown

Research Site, Kassel

Research Site, Érd

Research site, Nieuwegein

Research Site, Krakow

Research Site, Cluj-Napoca

Research Site, Chesterfield

All Listed Sponsors

lead

Mundipharma Research Limited

INDUSTRY

NCT00563056 - An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma | Biotech Hunter | Biotech Hunter